XJPX
2931
Market cap295mUSD
Oct 09, Last price
332.00JPY
1D
-0.90%
1Q
-3.77%
Jan 2017
-74.22%
IPO
100.97%
Name
Euglena Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Euglena Co., Ltd. is a Japanese enterprise specializing in the research, development, cultivation, and marketing of microalgae. Its operations are structured around two primary divisions: Healthcare Business and Energy/Environment Business. The company manufactures and sells a variety of euglena-derived food items and cosmetics. Additionally, it offers a broad portfolio of consumer goods, such as health foods, beverages, confectionery, and sports nutrition products. Furthermore, Euglena is engaged in pioneering biofuel and environmental technologies leveraging microalgae, and it makes strategic investments in the biotechnology sector. Its merchandise is distributed through numerous retail channels, including convenience stores, pharmacies, grocery stores, beauty parlors, and various specialty retailers. The company was established in Tokyo, Japan, in 2005.
Key people
Yuichi Hoshino
Chief Information Officer, Executive Officer · since 2022
Seong-hwan Kim
Senior Executive Officer · since 2024
Yosuke Inoue
Executive Officer, Director of New Business · since 2024
Nao Nitta
Executive Officer, Manager of Energy Company · since 2024
Daisuke Susa
Chief Administrative Officer, Executive Officer · since 2022
Yuko Suzuki
Executive Officer, Chief Legal Officer · since 2024
Mitsuru Izumo
President, Representative Director · since 2005
Director · since 2024
Hiroko Uemura
Co-Chief Executive Officer, Chief Operating Officer, Representative Executive Officer, Director · since 2024
Tomohiro Wakahara
Co-Chief Executive Officer, Chief Financial Officer, Representative Executive Officer, Director · since 2024
Independent Director · since 2018
Aiko Mochizuki
Independent Director · since 2020
Independent Director · since 2020
Yukiko Omura
Independent Director · since 2026
Makoto Shimizu
Independent Director · since 2015
Headquarters & legal address
港区芝5丁目29番11号
東京都, 13 108-0014
JP
東京都, 13 108-0014
JP
Other language
euglena Co. Ltd.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2021‑09 | 2020‑12 | 2020‑09 | 2019‑12 | 2019‑09 | 2018‑12 | 2018‑09 | 2017‑12 | 2017‑09 | 2016‑12 | |
| Income | |||||||||||||||
Revenues | |||||||||||||||
Cost of revenue | |||||||||||||||
Unusual Expense (Income) | |||||||||||||||
NOPBT | |||||||||||||||
NOPBT Margin | |||||||||||||||
Operating Taxes | |||||||||||||||
Tax Rate | |||||||||||||||
NOPAT | |||||||||||||||
Net income | |||||||||||||||
Dividends | |||||||||||||||
Dividend yield | |||||||||||||||
Proceeds from repurchase of equity | |||||||||||||||
BB yield | |||||||||||||||
| Debt | |||||||||||||||
Debt current | |||||||||||||||
Long-term debt | |||||||||||||||
Deferred revenue | |||||||||||||||
Other long-term liabilities | |||||||||||||||
Net debt | |||||||||||||||
| Cash flow | |||||||||||||||
Cash from operating activities | |||||||||||||||
CAPEX | |||||||||||||||
Cash from investing activities | |||||||||||||||
Cash from financing activities | |||||||||||||||
FCF | |||||||||||||||
| Balance | |||||||||||||||
Cash | |||||||||||||||
Long term investments | |||||||||||||||
Excess cash | |||||||||||||||
Stockholders' equity | |||||||||||||||
Invested Capital | |||||||||||||||
ROIC | |||||||||||||||
ROCE | |||||||||||||||
| EV | |||||||||||||||
Common stock shares outstanding | |||||||||||||||
Price | |||||||||||||||
Market cap | |||||||||||||||
EV | |||||||||||||||
EBITDA | |||||||||||||||
EV/EBITDA | |||||||||||||||
Interest | |||||||||||||||
Interest/NOPBT | |||||||||||||||